AzTrials
AzTrials

Psychiatric Adults PatientsMED@PSYNCT06581874

Evaluation of a Collaborative Mental Health Care System

A study testing Clinical assessment by emergency psychiatrist and Psychiatric consultation booked through Med@Psy platform in people with Psychiatric Adults Patients, run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer at 2 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In the absence of easy access to second-line ambulatory care, the number of 'inappropriate' psychiatric emergency visits is increasing, with emergency departments becoming the gateway to mental health care. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Psychiatric Adults Patients
What is being tested?
Clinical assessment by emergency psychiatrist and Psychiatric consultation booked through Med@Psy platform
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
418 participants
Where
2 sitesFrance
Study dates
3 Mar 2025to Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient ≥ 18 years ;
  • Patient presenting to the Centre hospitalier de Toulon La Seyne sur Mer emergency department, with or without referral, and receiving psychiatric advice with discharge without hospitalization after clinical assessment (Group 1) or patients referred for psychiatric consultation via the Med@psy system (Group 2).
  • Patient with indication for outpatient follow-up
  • Patient with open social security rights

Who cannot join

  • Patient's refusal to take part in research ;
  • Patient currently being followed by a psychiatrist. Psychiatric follow-up is defined as at least one consultation with a psychiatrist in the last 3 months, outside an unscheduled care consultation or in an emergency department;
  • Patients referred for a suicide attempt, violent or non-violent, serious or non-serious;
  • Patients without a declared general practioner;
  • Patients already included in the study;
  • Patients who do not speak French;
Show all 9Show fewer
  • Patients under judicial protection (guardianship, curatorship, etc.) or safeguard of justice;
  • Patient under compulsory care, under a care order or deprived of liberty.
  • Any other reason which, in the investigator's opinion, could interfere

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

France2 sites, 2 recruiting
  • Cabinet médical Korrichi (Med@psy program linked to this office)

    Toulon, Var, 83000

    Fabien Korrichi, MD, +33 4 94 38 37 53 ext. +33, docteurkorrichifabien@gmail.com

    Recruiting
  • Centre Hospitalier Intercommunal Toulon La Seyne sur Mer emergency reception service

    Toulon, Var, 83100

    Manuel Dias Alves, MD, +33 4 94 14 53 86 ext. +33, manuel.diasalves@ch-toulon.fr

    Recruiting

Other trials in France

About this study

In the absence of easy access to second-line ambulatory care, the number of 'inappropriate' psychiatric emergency visits is increasing, with emergency departments becoming the gateway to mental health care.

This is the context in which the 'med@psy' system was set up in the Toulon-Provence-Mediterranean metropolitan area by a private psychiatrist. It facilitates access to psychiatric second referral for General Practitioners (GPs) by pooling the 48-hour supply of psychiatric consultations in real time. It is assumed that this system will facilitate access to outpatient psychiatric care and help to optimize the organisation of patient care and follow-up. The aim of this study is to evaluate the med@psy system in the care pathway for patients with psychiatric disorders.

This study main objective is to compare the proportion of patients with a psychiatric disorder who will receive outpatient follow-up 1 month after a visit to a psychiatric emergency department without hospitalization (Group 1) versus 1 month after a consultation with a psychiatrist within 48 hours via the med@psy system (Group 2).

Read the detailed description

General practitioners (GPs) are the gateway to the healthcare system and therefore the first point of contact for mental health. A significant proportion of psychiatric disorders can be treated in primary care if GPs have easy access to psychiatric support. However, they are faced with difficulties in accessing secondary care. Around 9/10 consider that it is more difficult to obtain specialist advice than for other disciplines, and say they have difficulty referring a patient for mental health care.

In the absence of easy access to second-line ambulatory care, the number of 'inappropriate' psychiatric emergency visits is increasing, with emergency departments becoming the gateway to mental health care. It is recognized that the deployment of earlier and more graduated care reduces the intensity of disorders, prescriptions for time off work and psychotropic drugs, and hospitalizations.

A new, more preventive, efficient and cost-effective approach to mental health is emerging, with psychiatrists working closely with GPs. This is the context in which the 'med@psy' system was set up in the Toulon-Provence-Mediterranean metropolitan area by a private psychiatrist. It facilitates access to psychiatric second referral for GPs by pooling the 48-hour supply of psychiatric consultations in real time. We assume that this system will facilitate access to outpatient psychiatric care and help to optimize the organisation of patient care and follow-up. The aim of this study is to evaluate the med@psy system in the care pathway for patients with psychiatric disorders.

This study main objective is to compare the proportion of patients with a psychiatric disorder who will received outpatient follow-up 1 month after a visit to a psychiatric emergency department without hospitalization (Group 1) versus 1 month after a consultation with a psychiatrist within 48 hours via the med@psy system (Group 2).

Being tested
Clinical assessment by emergency psychiatrist, Psychiatric consultation booked through Med@Psy platform
Keywords
psychiatry, outpatient follow-up, emergency, ehealth, collaborative care
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clinical assessment by emergency psychiatristOther

    After a clinical assessment by the emergency department psychiatrist which does not lead to hospitalization, the patient will be given a psychiatric interview and sent home.

  • Psychiatric consultation booked through Med@Psy platformOther

    The patient will be seen within 48 hours after the consultation with his or her general practitioner by a psychiatrist taking part in the study.

Study groups in NCT06581874
Study groupRoleWhat they receive
EmergencySham comparatorAdult patients presenting to the emergency department of the Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer, whether or not referred by their general practitioner.
Receives: Other: Clinical assessment by emergency psychiatrist
Med@Psy PlatformExperimentalAdult patients referred by their general practioner for a psychiatric consultation via the med@psy system.
Receives: Other: Psychiatric consultation booked through Med@Psy platform

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients with a consultation with a psychiatrist, a psychologist or a general practioner one month after the consultation via the med@psy system or the visit to emergency department

    Setting up outpatient follow-up from a binary point of view (outpatient follow-up absent or present). This will be defined by whether or not each group has had at least one consultation with a psychiatrist (apart from emergency psychiatric consultations or psychiatric consultations set up at 48 hours with the system), a psychologist or a general practitioner.

    It will be evaluated by means of a telephone survey carried out among patients 1 month after consultation with a psychiatrist via the med@psy system or a visit to the emergency department.

    Measured: 1 month

Secondary outcomes (7)
  1. Outpatient follow-up at three months

    Outpatient follow-up will be evaluated by the proportion of patients who have had at least one consultation with a psychiatrist, psychologist or general practitioner, in each group, by means of a telephone survey carried out with patients 3 months after the consultation or visit to the emergency department.

    Measured: 3 months

  2. Medical partners commitment (part 1)

    Medical partners commitment will be assessed by the number of GPs and psychiatrists registered in the Med@psy program.

    Measured: 1 year

  3. Medical partners commitment (part 2)

    Medical partners commitment will be assessed by the number of patients treated via the program.

    Measured: 1 year

  4. Medical partners commitment (part 3)

    Medical partners commitment will be assessed by the frequency of use of Med@psy program.

    Measured: 1 year

  5. Medical partners commitment (part 4)

    Medical partners commitment will be assessed by the average time between referral by the GPs and the psychiatric consultations offered through the Med@psy program, 12 months after its start of use.

    Measured: 1 year

  6. Med@psy platform patients characteristics

    Description of the patient population who get a psychiatric consultation within 48 hours through the Med@psy platform but who don't come to the consultation. The elements which will be evaluated are : age, sex, place of residence, pathology and reason for referral by a GP.

    Measured: 1 month

  7. Functioning Global Assessment

    Overall psychological, social and professional functioning will be assessed using the Global Assessment of Functioning (GAF), which will be carried out by a psychologist during a teleconsultation with the patient at 1 and 3 months. Each time, GAF score will be assessed by a second psychologist on the basis of teleconsultation report and the two scores calculated will be compared. In case of different conclusions, the average of the two scores will be taken into account. GAF is a scale used to rate how serious a mental illness may be. It measures how much a person's symptoms affect their day-to-day life on a scale of 0 to 100. 100 corresponds to a better ability to handle daily activities.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Sep 2024
  2. Study start3 Mar 2025
  3. Primary completionMar 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
418 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06581874
Sponsor's protocol ID
2024-CHITS-005
Other IDs
2024-A01115-42
Acronym
MED@PSY
Status last verified
Jul 2026
First submitted
30 Aug 2024
Last updated
7 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Truelove S, Ng V, Kates N, Alloo J, Sunderji N, Patriquin MJ. Les soins de sante mentale en collaboration: Mobiliser les systemes de sante pour soutenir une approche d'equipe. Can Fam Physician. 2023 Feb;69(2):86-88. doi: 10.46747/cfp.690286. No abstract available. French.

    PubMed 36813512
  • Jones SH, Thornicroft G, Coffey M, Dunn G. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 1995 May;166(5):654-9. doi: 10.1192/bjp.166.5.654.

    PubMed 7620753
  • Kates N, Arroll B, Currie E, Hanlon C, Gask L, Klasen H, Meadows G, Rukundo G, Sunderji N, Ruud T, Williams M. Improving collaboration between primary care and mental health services. World J Biol Psychiatry. 2019 Dec;20(10):748-765. doi: 10.1080/15622975.2018.1471218. Epub 2018 Jun 20.

    PubMed 29722600
  • Dias Alves M, Jobic A, Rosso N, Abello M, Autret A, Vion-Dury J, Belzeaux R, Korrichi F. Evaluation of a collaborative care system in primary care in the implementation of ambulatory follow-up in mental health: A study protocol. PLoS One. 2026 Feb 25;21(2):e0343295. doi: 10.1371/journal.pone.0343295. eCollection 2026.

    PubMed 41739822

Questions about this trial

What is this clinical trial studying?

A study testing Clinical assessment by emergency psychiatrist and Psychiatric consultation booked through Med@Psy platform in people with Psychiatric Adults Patients, run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Asmaa Jobic (+33 4 83 77 20 61 ext. +33, asmaa.jobic@ch-toulon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients with a consultation with a psychiatrist, a psychologist or a general practioner one month after the consultation via the med@psy system or the visit to emergency department (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06581874, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in